A total of $600m has now been withdrawn from Odey Asset Management’s funds in the wake of multiple allegations of sexual assault and misconduct levelled against the firm’s founder Crispin Odey, according to a report by MorningStar.
Chris Rokos’s macro hedge fund has almost recovered from the losses it incurred earlier in the year because of wild swings in global interest rate markets, having posted a 4% gain last month on the back of a 5% return
Some of the world’s biggest macro traders slumped in the first six months of the year, with Andrew Law’s Caxton Macro hedge fund and Jeff Tallinn’s Element Capital Management among the big name managers seeing first half losses, according to
New York-based hedge fund firm Fir Tree Partners is looking to capitalise on the turmoil seen in the digital assets market over the past year or so by launching a hedge fund that will make investments in distressed crypto assets,
Davidson Kempner Capital Management has closed its Davidson Kempner Opportunities Fund VI, which will target investments in less liquid, longer-duration situations arising from capital dislocations, motivated sellers, and substantial asset or structural complexity, with $3bn in capital commitments. The five
Jonas Diedrich and Dave Sutton, former traders at Citadel, have raised $1.85bn for their new London-based hedge fund Ilex Capital Partners, exceeding their initial $1.7bn target, and making the new fund one of the biggest debuts of the year, according
The Arini Credit Master Fund, a $2.2bn hedge fund run by former Credit Suisse European debt specialist Hamza Lemssouguer, has racked up an 18% gain in the first half of the year, on the back of a 5.7% return in
Odey Asset Management’s Absolute Return fund is to reopen as the London-based hedge fund firm prepares for the transfer of manager James Hanbury to a rival firm in the aftermath of multiple allegations of sexual misconduct against Odey founder Crispin
GROW Investment Group, a China-based investment firm backed by Julius Baer Group and Navigator Global Investments, is looking to raise $50 million to buy stakes in domestic hedge fund managers.
Activist hedge fund Elliott Investment has acquired a stake in US drug manufacturer Catalent, after the New Jersey-headquartered, NYSE-listed company saw revenues plunge in the first quarter. Elliott is pushing for changes on Catalent’s board after Catalent’s Q1 fell 19%, according
